One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.1554.1554
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Northwestern University, Ospedale Papa Giovanni XXIII, University of Milan, University College London, Sarah Cannon, The University of Texas Health Science Center at San Antonio, Royal Marsden NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Hospital Universitario HM Sanchinarro, University of Bologna, Takeda (United States), Millennium Engineering and Integration (United States), Vall d'Hebron Hospital UniversitariPhase 1 Study of TAK-659, an Investigational Reversible Dual SYK/FLT-3 Inhibitor, in Patients (Pts) with Lymphoma: Updated Results from Dose-Escalation and Expansion Cohorts
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
